Kajiguchi Tomohiro, Ohno Toshihito
Hematology and Oncology Branch, Tosei General Hospital, Seto.
Intern Med. 2009;48(12):1089-91. doi: 10.2169/internalmedicine.48.2093. Epub 2009 Jun 15.
Azithromycin (AZM) is widely used for respiratory tract infections and otitis media because of its activity against Haemophilus influenzae and atypical pathogens, and its ease of administration. Although leukopenia is the one of the most frequent AZM-related laboratory abnormalities in children, agranulocytosis has not been reported in adults. Here, we present the case of an 81-year-old man with agranulocytosis following AZM-treatment for acute otitis media. He developed febrile neutropenia and granulocyte colony-stimulating factor and cefepim were administered. All his symptoms and absolute neutrophil counts were recovered within 7 days after admission. Physicians must be vigilant in identifying drug-induced neutropenia in AZM-treated patients because early detection can decrease the severity and prevent mortality.
阿奇霉素(AZM)因其对流感嗜血杆菌和非典型病原体具有活性且给药方便,被广泛用于治疗呼吸道感染和中耳炎。虽然白细胞减少是儿童中最常见的与AZM相关的实验室异常之一,但成人中尚未有粒细胞缺乏症的报道。在此,我们报告一例81岁男性在接受AZM治疗急性中耳炎后发生粒细胞缺乏症的病例。他出现了发热性中性粒细胞减少症,并给予了粒细胞集落刺激因子和头孢吡肟治疗。入院后7天内,他所有的症状和绝对中性粒细胞计数均恢复正常。医生在识别接受AZM治疗的患者中药物性中性粒细胞减少症时必须保持警惕,因为早期发现可降低严重程度并预防死亡。